IP Library Granted Patent US 8,758,704
Granted Patent B2
US 8,758,704 · App. 12/846,692 · Granted Jun 24, 2014

Microfluidic diagnostic device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,758,704
App. No.
12/846,692
Granted
Jun 24, 2014
Kind
B2
Abstract

A method of making a microfluidic diagnostic device for use in the assaying of biological fluids, whereby a layer of adhesive in a channel pattern is printed onto a surface of a base sheet and a cover sheet is adhered to the base sheet with the adhesive. The layer of adhesive defines at least one channel, wherein the channel passes through the thickness of the adhesive layer.

Claims (16)

1. A method of making a microfluidic diagnostic device, the method comprising:

printing a channel pattern onto a surface of a base sheet with one or more non-adhesive layers prior to printing a layer of adhesive onto the channel pattern, wherein the pattern defines at least one channel passing through the thickness of the adhesive; and

adhering a cover sheet to the base sheet with the adhesive to enclose the at least one channel when the cover sheet is adhered to the base sheet and wherein at least a portion of the channel has a mean width less than 1.0 mm, and wherein the cover sheet comprises at least one fluid sample inlet portal and at least one vent aperture each of which is configured to be in fluid communication with the at least one channel.

2. The method set forth in claim 1 , wherein the adhesive defines a plurality of channels and wherein adjacent channels are separated by adhesive and by non-channel space that is void of adhesive.

3. The method set forth in claim 1 , wherein either the base sheet or the cover sheet or both comprises a hydrophilic surface in contact with the at least one channel.

4. The method set forth in claim 1 , wherein at least a portion of the channel has a mean width less than 0.5 mm.

5. The method set forth in claim 1 , wherein the adhesive layer has a thickness ranging from 0.0025 mm to 0.25 mm.

6. The method set forth in claim 1 , wherein the channel forms a fluid flow path within which a fluid sample to be assayed can pass via capillary action.

7. The method set forth in claim 1 , wherein the adhesive is non-hydrophilic.

8. The method set forth in claim 1 , wherein the adhesive is pressure sensitive.

9. The method set forth in claim 1 , wherein the adhesive is printed to the base sheet by a technique selected from the group consisting of rotary or flat screen printing, pad printing, spray printing, offset printing, flexo graphic printing and transfer printing.

10. A microfluidic diagnostic device adapted for use in the assaying of biological fluids, the device comprising:

a base sheet;

one or more non-adhesive layers disposed on a surface of the base sheet in a channel pattern, and an adhesive layer disposed on the channel pattern wherein the adhesive defines at least one fluid transport channel, the channel having a mean width less than 0.6 mm;

a cover sheet adhered to the base sheet by means of the adhesive, wherein the cover sheet encloses the at least one channel when the cover sheet is adhered to the base sheet; and

wherein either the base sheet or the cover sheet or both comprise a hydrophilic surface in contact with the adhesive, and wherein the cover sheet comprises at least one fluid sample inlet portal and at least one vent aperture each of which is configured to be in fluid communication with the at least one channel.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Nov 26, 2024
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: BARIL CORPORATION; TEAM TECHNOLOGIES, INC.; ICP MEDICAL, LLC; PROTEXER, INC.; DOSELOGIX, LLC
Reel/Frame 069414/0556 →
RELEASE OF SECURITY INTEREST Recorded Nov 26, 2024
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: BARIL CORPORATION; TEAM TECHNOLOGIES, INC.; ICP MEDICAL, LLC; PROTEXER, INC.; DOSELOGIX, LLC
Reel/Frame 069414/0564 →
MEMORANDUM OF SECURITY INTEREST IN PATENTS Recorded Nov 22, 2024
From: BARIL CORPORATION
To: BLUE OWL CAPITAL CORPORATION
Reel/Frame 069436/0279 →
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME NO.: 053682/0033 Recorded Jan 4, 2022
From: ACF FINCO I LP
To: BARIL CORPORATION
Reel/Frame 058570/0843 →
RELEASE OF FIRST LIEN SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME NO.: 053682/0243 Recorded Jan 4, 2022
From: ARES CAPITAL CORPORATION
To: BARIL CORPORATION
Reel/Frame 058570/0834 →
RELEASE OF SECOND LIEN SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME NO.: 053686/0946 Recorded Jan 4, 2022
From: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
To: BARIL CORPORATION
Reel/Frame 058570/0838 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2022
From: BARIL CORPORATION; DOSELOGIX, LLC; ICP MEDICAL, LLC; PROTEXER, INC.; TEAM TECHNOLOGIES, INC.
To: BANK OF MONTREAL, AS COLLATERAL AGENT
Reel/Frame 058570/0475 →
INTELLECTUAL PROPERTY SECURITYAGREEMENT Recorded Jan 3, 2022
From: BARIL CORPORATION; DOSELOGIX, LLC; ICP MEDICAL, LLC; PROTEXER, INC.; TEAM TECHNOLOGIES, INC.
To: BANK OF MONTREAL, AS COLLATERAL AGENT
Reel/Frame 058570/0492 →
SECURITY INTEREST Recorded Sep 3, 2020
From: BARIL CORPORATION
To: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
Reel/Frame 053686/0946 →
SECURITY INTEREST Recorded Sep 3, 2020
From: BARIL CORPORATION
To: ACF FINCO I LP
Reel/Frame 053682/0033 →
FIRST LIEN SECURITY INTEREST Recorded Sep 3, 2020
From: BARIL CORPORATION
To: ARES CAPITAL CORPORATION
Reel/Frame 053682/0243 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2020
From: BARIL, DANIEL J.
To: BARIL CORPORATION
Reel/Frame 053654/0132 →